Key result
Valsartan lowered the systolic blood pressure response to angiotensin II challenges compared to placebo, with effects maintained up to 24 hours.
Why the study?
Does valsartan 80 mg reduce the angiotensin II pressor response in healthy normotensive men?
RCT (n=6)
Double-blind
crossover
No
Does valsartan 80 mg reduce the angiotensin II pressor response in healthy normotensive men?
Valsartan 80 mg provides rapid and persistent inhibition of the angiotensin II pressor response for up to 24 hours, with no attenuation after 7 days of multiple dosing.
Answers are grounded in this paper and cite their sources.
Supports once-daily valsartan dosing; confirms sustained AT1 blockade without attenuation over 7 days.
OBJECTIVE: Valsartan is an oral antagonist of angiotensin II that competes with angiotensin II for the AT1-receptor and is being developed as an antihypertensive agent. This study assessed the ability of 80 mg valsartan to inhibit the pressor effect of exogenous angiotensin II in healthy normotensive men, first after a single dose and then after multiple doses once daily for 7 days. METHODS: This was a single-center, double-blind, placebo-controlled, randomized crossover study. Six healthy men underwent angiotensin II challenges to determine a suitable dose required to increase their systolic blood pressure by approximately 30 mm Hg. Each subject then received an 80 mg dose of valsartan or matching placebo. The inhibition of the angiotensin II pressor effect was determined by the systolic blood pressure response to repeated angiotensin II challenges at multiple time points. RESULTS: Systolic blood pressure responses to angiotensin II challenges after single and multiple doses of valsartan were significantly lower than placebo, indicating that valsartan blocked the blood pressure response to angiotensin II. The maximum blocking effect was observed within 2 to 3 hours. Mean data suggested that differences in effect between valsartan and placebo were similar after both single and multiple doses and persisted up to 24 hours after administration. The angiotensin II blocking effect was maintained up to this time, despite low plasma valsartan levels and minimal accumulation after multiple doses. CONCLUSION: Valsartan, 80 mg, is a potent angiotensin II antagonist with a rapid onset of action and persistent angiotensin II inhibition up to 24 hours. There is no attenuation of this effect after multiple doses.
No takes yet. Share an insight, caveat, or question.
Morgan et al. (1997) conducted an RCT in Healthy normotensive (n=6). Valsartan vs. Placebo was evaluated on Systolic blood pressure response to repeated angiotensin II challenges. Valsartan lowered the systolic blood pressure response to angiotensin II challenges compared to placebo, with effects maintained up to 24 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: